CAS: 166173-78-0 - (S)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXY-N-[[(2S)-1-(2-PROPENYL)-2-PYRROLIDINYL]METHYL]-
Formula:C20H29FN2O3
InChI:InChI=1S/C20H29FN2O3/c1-4-10-23-11-6-8-16(23)14-22-20(24)17-12-15(7-5-9-21)13-18(25-2)19(17)26-3/h4,12-13,16H,1,5-11,14H2,2-3H3,(H,22,24)/t16-/m0/s1
InChI key:InChIKey=OABRYNHZQBZDMG-INIZCTEOSA-N
SMILES:O=C(NCC1N(CC=C)CCC1)C2=CC(=CC(OC)=C2OC)CCCF
- Synonyms:
- 5-(3-Fluoropropyl)-2,3-dimethoxy-N-[[(2S)-1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]benzamide
- Benzamide, 5-(3-Fluoropropyl)-2,3-Dimethoxy-N-[[(2S)-1-(2-Propenyl)-2-Pyrrolidinyl]Methyl]-
- Benzamide, 5-(3-fluoropropyl)-2,3-dimethoxy-N-[[(2S)-1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-
- Benzamide, 5-(3-fluoropropyl)-2,3-dimethoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-, (S)-
- Fallypride
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Fallypride REF: TR-F101115CAS: 166173-78-0 | - - - | 10,963.00 € | Tue 07 Jan 25 | |
Fallypride REF: 3D-RGA17378CAS: 166173-78-0 | Min. 95% | To inquire | Tue 07 Jan 25 | |
Fallypride REF: TM-T70302CAS: 166173-78-0 | 100% - 99.17% | 355.00 €~2,611.00 € | Tue 14 Jan 25 |
Fallypride
Controlled ProductCAS:166173-78-0
Formula:
C20H29FN2O3
Color and Shape:
Neat
Molecular weight:
364.454
Ref: TR-F101115
250mg | 10,963.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Fallypride
CAS:166173-78-0
Fallypride is a dopamine receptor agonist that has been shown to be effective in vitro …
Formula:
C20H29FN2O3
Purity:
Min. 95%
Molecular weight:
364.5 g/mol
Ref: 3D-RGA17378
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Fallypride
CAS:166173-78-0
Fallypride is a potent and selective dopamine D2/D3 receptor antagonist.
Formula:
C20H29FN2O3
Purity:
100% - 99.17%
Color and Shape:
Liquid
Molecular weight:
364.45
Ref: TM-T70302
1mg | 355.00 € | ||
5mg | 831.00 € | ||
10mg | 1,023.00 € | ||
25mg | 1,623.00 € | ||
50mg | 2,033.00 € | ||
100mg | 2,611.00 € | ||
1mL*10mM (DMSO) | 668.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025